OASYS System

K150753 · Stryker Corporation · KWP · Jun 9, 2015 · Orthopedic

Device Facts

• Record ID: K150753
• Device Name: OASYS System
• Applicant: Stryker Corporation
• Product Code: KWP · Orthopedic
• Decision Date: Jun 9, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3050
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

When intended to promote fusion of the cervical spine and occipito-cervico-thoracic junction (Occiput-T3), the STRYKER Spine Oasys System is intended for: • Degenerative Disc Disease (as defined by neck and back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies) • Spondylolisthesis • Spinal Stenosis • Fracture/Dislocation • Atlanto/axial fracture with instability • Occipitocervical dislocation • Revision of previous cervical spine surgery • Tumors When used with the occipital plate, the bone screws are limited to occipital fixation only. The bone screws are not intended to be used in the cervical spine. The use of the polyaxial screws is limited to placement in the upper thoracic spine (T1 -T3 ). They are not intended to be placed in the cervical spine. The hooks and rods are also intended to provide stabilization following reduction of fracture/dislocation or trauma in the cervical/upper thoracic (C1-T3) spine. The Stryker Spine OASYS® System can be linked to the Xia® System and Xia® 4.5 Spinal System via the rod-to-rod connectors and transition rods. The Stryker Spine OASYS® System can also be linked to the polyaxial screws of Xia® II and Xia® 3 System via the saddle connector.

Device Story

OASYS® System is a spinal fixation orthosis; components include rods, polyaxial screws, bone screws, hooks, connectors, and occiput plates. Used by surgeons in clinical settings to stabilize the cervical/upper thoracic spine (C1-T3) to promote fusion. System components are linked to provide structural support; can be integrated with Stryker Xia® and SR90D systems via connectors. Provides mechanical stabilization for patients with spinal instability or deformity; benefits include structural support during bone healing. Non-sterile components are implanted during surgery.

Clinical Evidence

Bench testing only. Engineering analysis performed to verify that the addition of longer transition rods does not impact the mechanical performance of the system.

Technological Characteristics

Components fabricated from Titanium alloy, CP Titanium, and Vitallium®. System includes rods, polyaxial screws, bone screws, hooks, connectors, and occiput plates. Non-sterile. Mechanical fixation principle. No software or energy source.

Indications for Use

Indicated for patients requiring cervical/occipito-cervico-thoracic (Occiput-T3) fusion due to degenerative disc disease, spondylolisthesis, spinal stenosis, fracture/dislocation, atlanto/axial fracture with instability, occipitocervical dislocation, revision surgery, or tumors. Contraindicated for cervical placement of polyaxial screws (T1-T3 only) and bone screws (occipital only).

Regulatory Classification

Identification

A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome.

Predicate Devices

• Stryker Spine OASYS® System (K142741)

Reference Devices

• Xia® System
• Xia® 4.5 Spinal System
• SR90D System
• Xia® II System
• Xia® 3 System

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of three faces in profile, stacked one behind the other, representing the department's mission to protect the health of all Americans and provide essential human services.

June 9, 2015

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Stryker Cornoration Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

Re: K150753

Trade/Device Name: OASYS® System Regulation Number: 21 CFR 888.3050 Regulation Name: Spinal interlaminal fixation orthosis Regulatory Class: Class II Product Code: KWP Dated: April 9, 2015 Received: April 10, 2015

Dear Dr. Hayeck:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{1}------------------------------------------------

Page 2 - Garry T. Hayeck, Ph.D.

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely vours.

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K150753

Device Name OASYS® System

Indications for Use (Describe)

When intended to promote fusion of the cervical spine and occipito-cervico-thoracic junction (Occiput-T3), the STRYKER Spine Oasys System is intended for:

· Degenerative Disc Disease (as defined by neck and back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies)

- · Spondylolisthesis
- · Spinal Stenosis
- · Fracture/Dislocation
- Atlanto/axial fracture with instability
- · Occipitocervical dislocation
- · Revision of previous cervical spine surgery
- Tumors

When used with the occipital plate, the bone screws are limited to occipital fixation only. The bone screws are not intended to be used in the cervical spine.

The use of the polyaxial screws is limited to placement in the upper thoracic spine (T1 -T3 ). They are not intended to be placed in the cervical spine.

The hooks and rods are also intended to provide stabilization following reduction of fracture/dislocation or trauma in the cervical/upper thoracic (C1-T3) spine.

The Stryker Spine OASYS® System can be linked to the Xia® System and Xia® 4.5 Spinal System via the rod-to-rod connectors and transition rods.

The Stryker Spine OASYS® System can also be linked to the polyaxial screws of Xia® II and Xia® 3 System via the saddle connector.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

#### FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

{3}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

| 510(k) Summary: OASYS® System | |
|--------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter | Stryker Corporation<br>2 Pearl Court<br>Allendale, NJ 07401 |
| Contact Person | Garry T. Hayeck, Ph.D.<br>Senior Regulatory Affairs Specialist<br>Phone: [phone]<br>Fax: [phone]<br>E-mail: [e-mail] |
| Date Prepared | March 20, 2015 |
| Trade Name | OASYS® System |
| Common Name | Spinal Fixation Appliances |
| Proposed Class | Class II |
| Classification Name,<br>Codification | Spinal Interlaminal Fixation Orthosis, 21 CFR § 888.3050 |
| Product Codes | KWP |
| Predicate Devices | <b>Primary Predicate:</b><br>Stryker Spine OASYS® System: K142741 |
| Device Description | The Stryker Spine OASYS® System is comprised of rods, polyaxial<br>screws, bone screws, hooks, connectors, and occiput plates. The<br>components are available in a variety of lengths in order to<br>accommodate patient anatomy. The components are fabricated<br>from Titanium alloy and CP Titanium and are provided non-sterile. The<br>subject system also offers Vitallium® rods. The Stryker Spine OASYS®<br>System can be linked to the Stryker Spine Xia® family and Xia 4.5<br>Systems and SR90D System. |
| Indications for Use | When intended to promote fusion of the cervical spine and occipito-<br>cervico-thoracic junction (Occiput-T3), the STRYKER Spine Oasys<br>System is intended for:<br>• Degenerative Disc Disease (as defined by neck and back pain of<br>discogenic origin with degeneration of the disc confirmed by history<br>and radiographic studies)<br>• Spondylolisthesis<br>• Spinal Stenosis<br>• Fracture/Dislocation<br>• Atlanto/axial fracture with instability<br>• Occipitocervical dislocation<br>• Revision of previous cervical spine surgery<br>• Tumors<br><br>When used with the occipital plate, the bone screws are limited to<br>occipital fixation only. The bone screws are not intended to be used in<br>the cervical spine.<br><br>The use of the polyaxial screws is limited to placement in the upper<br>thoracic spine (T1 -T3). They are not intended to be placed in the<br>cervical spine. |
| | The hooks and rods are also intended to provide stabilization to<br>promote fusion following reduction of fracture/dislocation or trauma in<br>the cervical/upper thoracic (C1-T3) spine. |
| | The Stryker Spine OASYS® System can be linked to the Xia® System,<br>SR90D System and Xia® 4.5 Spinal System via the rod-to-rod<br>connectors and transition rods. |
| | The Stryker Spine OASYS® System can also be linked to the polyaxial<br>screws of Xia® II and Xia® 3 System via the saddle connector. |
| Summary of | The subject OASYS® System shares the same materials, geometries, |
| Technological | and fundamental scientific technologies as predicate OASYS® |
| Characteristics | Systems. The proposed new transition rods are identical to previously<br>cleared OASYS® transition rods with the exception that thoracolumbar<br>section of the rod is longer in length. |
| Summary of | An engineering analysis was performed to demonstrate that the |
| Performance Data | addition of the longer length transition rods does not affect the<br>performance of the OASYS® System. |
| Conclusion | The devices, methodologies, and materials used in this system are<br>equivalent to previously cleared OASYS® Systems. As such, the<br>subject system is substantially equivalent to previously cleared<br>OASYS® Systems. |

{5}------------------------------------------------